All In Biotech

Drug Trial Radar · NCT00800605

Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection

Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection

Last checked: Nov 20, 2026Latest source record: Nov 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 7,250 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

7,250

Actual

Start

Dec 2008

Primary completion

May 2009

Study completion Jun 2009

Sponsor

Sponsor type
Industry
First posted
Dec 2, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Prevention
Who can join
All sexes, from 18 years, up to 49 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to demonstrate the efficacy of an investigational Vero cell-derived, trivalent, seasonal influenza vaccine to prevent infection with an influenza virus that is antigenically similar to one of the three strains in the vaccine. Subjects will be randomized in a double-blind fashion to receive a single intramuscular injection of either the investigational vaccine or placebo. Blood will be drawn from all subjects for a determination of hemagglutination inhibition antibody titers on Days 0 and 21, body temperature and injection site reactions will be monitored daily for 7 days. In addition, subjects must return to the clinic promptly to have swab samples of their nose and throat taken whenever they feel flu symptoms and all subjects will be monitored for adverse events until Day 180.

Conditions

  • Influenza

Interventions

  • Vero cell-derived, trivalent, seasonal influenza vaccineBiological

    Single intramuscular injection

  • Placebo: Phosphate-buffered salineBiological

    Single intramuscular injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Efficacy of an Investigational Vero Cell-derived Influenza Vaccine to Prevent Infection With an Influenza Virus That is Antigenically Similar to One of the Three Strains in the VaccineTime frame: 180 days

Locations

36 sites in 1 country. Site status is shown where the registry gives one.

  • Quality of Life Medical & Research Center, LLC

    Tucson, Arizona

  • Benchmark Research

    Sacramento, California

  • California Research Foundation

    San Diego, California

  • Benchmark Research San Francisco

    San Francisco, California

  • Radiant Research, Inc

    Denver, Colorado

  • Clinical Research of South Florida

    Coral Gables, Florida

  • Jacksonville Center for Clinical Research

    Jacksonville, Florida

  • Pharmax Research Clinic

    Miami, Florida

  • University Clinical Research, Inc

    Pembroke Pines, Florida

  • Miami Research Associates

    South Miami, Florida

  • Clinical Research Atlanta

    Stockbridge, Georgia

  • Radiant Research, Inc - Chicago

    Chicago, Illinois

  • Johnson County Clin-Trials

    Lenexa, Kansas

  • Vince and Associates Clinical Research

    Overland Park, Kansas

  • Central Kentucky Research Associates, Inc.

    Lexington, Kentucky

  • Benchmark Research

    Metairie, Louisiana

  • Center for Pharmaceutical Research

    Kansas City, Missouri

  • Radiant Research, Inc.

    St Louis, Missouri

  • Sundance Clinical Research

    St Louis, Missouri

  • Meridian Clinical Research, LLC

    Omaha, Nebraska

  • Regional Clinical Research, Inc.

    Endwell, New York

  • Rochester Clinical Research, Inc.

    Rochester, New York

  • Triangle Medical Research Associates

    Raleigh, North Carolina

  • Wake Research Associates, LLC

    Raleigh, North Carolina

  • Radiant Research - Cincinnati

    Cincinnati, Ohio

  • Omega Medical Research

    Warwick, Rhode Island

  • Spartanburg Medical Research

    Spartanburg, South Carolina

  • Health Concepts

    Rapid City, South Dakota

  • Clinical Research Associates, Inc. - Nashville

    Nashville, Tennessee

  • Benchmark Research Austin

    Austin, Texas

  • Benchmark Research Ft. Worth

    Fort Worth, Texas

  • Benchmark Research San Angeolo

    San Angelo, Texas

  • Jean Brown Research / Westside Medical

    Salt Lake City, Utah

  • Advanced Clinical Research

    West Jordan, Utah

  • PI-COOR Clinical Research

    Burke, Virginia

  • Clinical Research Associates of Tidewater

    Norfolk, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.